FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294132023> ?p ?o ?g. }

• W4294132023 endingPage "1740" @default.
• W4294132023 startingPage "1740" @default.
• W4294132023 abstract "Atopic dermatitis (AD) is a chronic inflammatory skin disease accompanied by severe itching and dry skin. Currently, the incidence of AD due to excessive activation of immune cells by various environmental factors is increasing worldwide, and research on inflammatory response inhibitors with fewer side effects is continuously needed. Cynanoside F (CF) is one of the pregnane-type compounds in the root of Cynanchum atratum, an oriental medicinal herb that has been shown to have antioxidant, antitumor, and anti-inflammatory effects. Although CF has been isolated as a component in Cynanchum atratum, the scientific role of CF has not yet been explored. In this study, we evaluated the effect of CF on AD and revealed the mechanism using in vitro and in vivo experimental models. CF significantly reduced lipopolysaccharide (LPS)-induced protein expression levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), and cyclooxygenase-2 (COX-2), which are important proinflammatory mediators in the RAW264.7 macrophage cell line. CF did not inhibit the nuclear factor-kappa B (NF-κB) signaling activated by LPS but significantly reduced the phosphorylation of mitogen-activated protein kinases (MAPKs), such as p38 MAPK, JNK, and ERK. CF consistently inhibited the activity of the activator protein-1 (AP-1) transcription factor, a downstream molecule of MAPK signaling. In addition, in an experiment using an oxazolone-induced AD mouse model, the CF-treated group showed a marked decrease in epidermal thickness, the number of infiltrated mast cells, and the amount of histamine. The mRNA levels of IL-1β, interleukin-4 (IL-4), and thymic stromal lymphopoietin (TSLP) were consistently lowered in the group treated with CF. Moreover, the phosphorylation of c-Jun and c-Fos protein levels, which are the AP-1 components, were lowered in the skin tissues of CF-treated mice. These results provide the first evidence that CF has an inhibitory effect on AD and suggest the possibility of CF being developed as a potential therapeutic agent for AD." @default.
• W4294132023 created "2022-09-02" @default.
• W4294132023 creator A5035890339 @default.
• W4294132023 creator A5053334597 @default.
• W4294132023 creator A5055128041 @default.
• W4294132023 creator A5066219125 @default.
• W4294132023 date "2022-09-01" @default.
• W4294132023 modified "2023-09-30" @default.
• W4294132023 title "Cynanoside F Controls Skin Inflammation by Suppressing Mitogen-Activated Protein Kinase Activation" @default.
• W4294132023 cites W1562948341 @default.
• W4294132023 cites W1972300471 @default.
• W4294132023 cites W1973956018 @default.
• W4294132023 cites W1998729178 @default.
• W4294132023 cites W2013763811 @default.
• W4294132023 cites W2016818237 @default.
• W4294132023 cites W2024392143 @default.
• W4294132023 cites W2039244674 @default.
• W4294132023 cites W2039442454 @default.
• W4294132023 cites W2052743475 @default.
• W4294132023 cites W2107277218 @default.
• W4294132023 cites W2134261811 @default.
• W4294132023 cites W2145722383 @default.
• W4294132023 cites W2192080449 @default.
• W4294132023 cites W2302524766 @default.
• W4294132023 cites W2604389567 @default.
• W4294132023 cites W2630335709 @default.
• W4294132023 cites W2729916652 @default.
• W4294132023 cites W2735527928 @default.
• W4294132023 cites W2803170756 @default.
• W4294132023 cites W2804494840 @default.
• W4294132023 cites W2904897603 @default.
• W4294132023 cites W2936207686 @default.
• W4294132023 cites W2939497858 @default.
• W4294132023 cites W2943979662 @default.
• W4294132023 cites W3022161894 @default.
• W4294132023 cites W3042682551 @default.
• W4294132023 cites W3092128237 @default.
• W4294132023 cites W3132984071 @default.
• W4294132023 cites W3164790136 @default.
• W4294132023 cites W3171487497 @default.
• W4294132023 cites W3209156318 @default.
• W4294132023 cites W4211145137 @default.
• W4294132023 cites W4214614577 @default.
• W4294132023 cites W4224943603 @default.
• W4294132023 cites W4281391759 @default.
• W4294132023 doi "https://doi.org/10.3390/antiox11091740" @default.
• W4294132023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36139814" @default.
• W4294132023 hasPublicationYear "2022" @default.
• W4294132023 type Work @default.
• W4294132023 citedByCount "1" @default.
• W4294132023 countsByYear W42941320232023 @default.
• W4294132023 crossrefType "journal-article" @default.
• W4294132023 hasAuthorship W4294132023A5035890339 @default.
• W4294132023 hasAuthorship W4294132023A5053334597 @default.
• W4294132023 hasAuthorship W4294132023A5055128041 @default.
• W4294132023 hasAuthorship W4294132023A5066219125 @default.
• W4294132023 hasBestOaLocation W42941320231 @default.
• W4294132023 hasConcept C164027704 @default.
• W4294132023 hasConcept C184235292 @default.
• W4294132023 hasConcept C185592680 @default.
• W4294132023 hasConcept C203014093 @default.
• W4294132023 hasConcept C2776914184 @default.
• W4294132023 hasConcept C51551487 @default.
• W4294132023 hasConcept C55493867 @default.
• W4294132023 hasConcept C57074206 @default.
• W4294132023 hasConcept C71924100 @default.
• W4294132023 hasConcept C97029542 @default.
• W4294132023 hasConcept C98274493 @default.
• W4294132023 hasConceptScore W4294132023C164027704 @default.
• W4294132023 hasConceptScore W4294132023C184235292 @default.
• W4294132023 hasConceptScore W4294132023C185592680 @default.
• W4294132023 hasConceptScore W4294132023C203014093 @default.
• W4294132023 hasConceptScore W4294132023C2776914184 @default.
• W4294132023 hasConceptScore W4294132023C51551487 @default.
• W4294132023 hasConceptScore W4294132023C55493867 @default.
• W4294132023 hasConceptScore W4294132023C57074206 @default.
• W4294132023 hasConceptScore W4294132023C71924100 @default.
• W4294132023 hasConceptScore W4294132023C97029542 @default.
• W4294132023 hasConceptScore W4294132023C98274493 @default.
• W4294132023 hasFunder F4320321681 @default.
• W4294132023 hasFunder F4320322120 @default.
• W4294132023 hasIssue "9" @default.
• W4294132023 hasLocation W42941320231 @default.
• W4294132023 hasLocation W42941320232 @default.
• W4294132023 hasLocation W42941320233 @default.
• W4294132023 hasOpenAccess W4294132023 @default.
• W4294132023 hasPrimaryLocation W42941320231 @default.
• W4294132023 hasRelatedWork W1976734851 @default.
• W4294132023 hasRelatedWork W1988519514 @default.
• W4294132023 hasRelatedWork W1991969187 @default.
• W4294132023 hasRelatedWork W2005481865 @default.
• W4294132023 hasRelatedWork W2013052548 @default.
• W4294132023 hasRelatedWork W2016907940 @default.
• W4294132023 hasRelatedWork W2067160292 @default.
• W4294132023 hasRelatedWork W2070643674 @default.
• W4294132023 hasRelatedWork W2419118008 @default.
• W4294132023 hasRelatedWork W4254421120 @default.
• W4294132023 hasVolume "11" @default.

• next